Patent details

Basic Information

Publication number:

EP1816204

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP071060446

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Recombinant Adenovirus of the Ad26 serotype

French Title of Invention:

Adénovirus recombinant du sérotype Ad26

German Title of Invention:

Rekombinantes Adenovirus des Ad26-Serotyps

SPC Number:

Dates

Filing date:

16/05/2000

Grant date:

20/10/2010

EP Publication Date:

20/10/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/08/2007

EP B1 Publication Date:

20/10/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/05/2015

Expiration date:

16/05/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/05/2000

 

 

Name:

Crucell Holland B.V.

Address:

Archimedesweg 4, 2333 CN Leiden, Netherlands (NL)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

27/10/2010

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Havenga Menzo Jans Emko

Address:

Netherlands (NL)

2

Name:

Vogels Ronald

Address:

Netherlands (NL)

3

Name:

Bout Abraham

Address:

Netherlands (NL)

Priority

Priority Number:

99201545

Priority Date:

17/05/1999

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C12N 15/86;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages